Binh Dinh Pharmaceutical and Medical Equipment JSC (Bidiphar – Ticker: DBD) is proud to announce its official inclusion in the Top 10 Mid Cap finalists at the IR Awards 2025. This prestigious annual award, organized by Vietstock, VAFE, and FiLi Magazine, honors listed companies in Vietnam demonstrating excellence, transparency, and efficiency in Investor Relations (IR) activities.
1. Bidiphar’s Achievement at IR Awards 2025
After passing rigorous quantitative surveys regarding information disclosure, liquidity, and corporate governance, Bidiphar successfully secured its place on the shortlist for the IR Awards 2025 final round.
Entering the Top Mid Cap category (Medium Capitalization Companies) not only confirms Bidiphar’s robust financial health but also serves as a testament to the company’s commitment to:
Information Transparency: Ensuring shareholders receive timely and accurate data.
Professional Governance: Adhering to modern corporate governance standards.
Shareholder Respect: Maintaining an open dialogue channel with the investment community.
Alongside Bidiphar (DBD), this year’s Top 10 Mid Cap list features other prominent names such as Coteccons (CTD), Dabaco (DBC), Digiworld (DGW), and Tien Phong Plastic (NTP).
2. Voting Guide for Bidiphar (DBD)
The final round of IR Awards 2025 involves two primary evaluation categories:
Most Highly Appreciated by Financial Institutions: Scored by nearly 40 investment funds and securities companies.
Most Loved by Investors: Open for public voting by the investment community.
To support Bidiphar in promoting the image of a reputable pharmaceutical enterprise, Shareholders and Investors are invited to participate in the voting process as follows:
Voting Period: From August 1, 2025, to August 14, 2025.
Official Voting Link: https://ir.vietstock.vn/binh-chon-dai-chung.htm
How to Vote: Access the link, locate the stock symbol DBD in the Mid Cap group, and cast your vote.
Note: Your vote is a significant motivation for Bidiphar to continue perfecting our management practices and delivering sustainable value to shareholders and the community.
3. IR Awards – 15 Years of Setting Standards
The year 2025 marks the 15th anniversary of the IR Awards in fostering a culture of transparency within the Vietnam stock market.
The award is not merely a title but a benchmark of credibility, assisting financial institutions and individual investors in screening for high-quality companies (“Quality Stocks”). Bidiphar’s presence in this list reaffirms its position as a potential and safe pharmaceutical stock for long-term investment portfolios.
The Honoring Ceremony is expected to take place in September 2025 in Ho Chi Minh City.
Key Takeaways for Investors:
Event: IR Awards 2025 Final Round.
Category: Top 10 Mid Cap.
Company: Bidiphar (Ticker: DBD).
Call to Action: Vote at Vietstock from Aug 01–14, 2025.
